AI news ·
Aignostics launches HETA Clinical for pathology workflows
Aignostics launched four research-use tools that automate whole-slide image analysis for pathology, but they are not approved for diagnosis.

Aignostics has introduced HETA Clinical, a set of four research-use products designed to assist with pathology workflows by analyzing whole-slide images. The tools are built to assess slide quality, identify tumor regions, count mitotic figures, and evaluate cellularity in digitized tissue samples.
The products are intended to support pathology research activities by automating elements of image review that are typically performed manually. However, the company states that these tools are not cleared or approved for diagnostic use. Any application in a clinical setting would require thorough validation to confirm performance and reliability before adoption.
By focusing on common pre-analytical and analytical tasks in whole-slide imaging, the suite may help laboratories structure their research processes more efficiently. The launch adds to a growing category of computational pathology tools aimed at research environments, where consistent and reproducible image assessment remains a key challenge.